Type: Session Therapeutic: Cardiovascular Medicine,Geriatrics,Nephrology
Friday May 11 10:15am to 11:15am Location: Lecture Hall 1 Credits: 1 Mainpro+
For many years, the Canadian Hypertension Education Program (CHEP) has provided guidance to clinicians on how to diagnose and treat high blood pressure. Recently, the CHEP recommendations have been renamed the Hypertension Canada Guidelines. In addition to a name change, there have been several important changes to how hypertension is diagnosed, the target blood pressure in certain populations, and to the list of recommended first line therapies in uncomplicated hypertension. This interactive lecture will review some of these important changes to the hypertension guidelines.
Discuss changes to the measurement of blood pressure in the office.
Debate which patients should be targeted for a systolic blood pressure target of <120 mmHg.
Review changes to the list of recommended first line therapies in hypertension without compelling indications.
Phil Mcfarlane MD, PhD, FRCP(C) Dr. Phil McFarlane is a clinical-investigator in the Division of Nephrology at St. Michael's Hospital in Toronto, and an
assistant professor at the University of Toronto. At St. Michael’s he is the Medical Director of Home Dialysis and the Chief Nephrologist in the Live Kidney Donor Program. He is a member of the Diabetes Canada Clinical Practice
Guidelines group, the Canadian Society of Nephrology guideline group, and the Hypertension Canada guideline group. He has completed his Ph.D. in health economics at the Institute for Medical Sciences at the University of Toronto. His areas of research interest include health economics and outcomes research. He is currently the Provincial Medical Lead for dialysis access and home hemodialysis. He has published over 90 peer-reviewed manuscripts and three book chapters.